|
|
Volumn 333, Issue 6038, 2011, Pages 27-
|
|
As E. coli outbreak recedes, new questions come to the fore
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AUTOANTIBODY;
ECULIZUMAB;
MONOCLONAL ANTIBODY;
BACTERIAL DISEASE;
COLIFORM BACTERIUM;
DISEASE SEVERITY;
HEALTH RISK;
LITERATURE REVIEW;
PUBLIC HEALTH;
SURVIVAL;
TEMPORAL ANALYSIS;
BACTERIUM IDENTIFICATION;
DRUG EFFICACY;
ENTEROAGGREGATIVE ESCHERICHIA COLI;
ENTEROHEMORRHAGIC ESCHERICHIA COLI;
EPIDEMIC;
ESCHERICHIA COLI INFECTION;
GERMANY;
HUMAN;
INFECTION RISK;
PRIORITY JOURNAL;
SHORT SURVEY;
BACTERIUM ADHERENCE;
GENETICS;
HEMOLYTIC UREMIC SYNDROME;
MICROBIOLOGY;
NOTE;
PATHOGENICITY;
PLASMAPHERESIS;
ANTIBODIES, MONOCLONAL;
AUTOANTIBODIES;
BACTERIAL ADHESION;
DISEASE OUTBREAKS;
ENTEROHEMORRHAGIC ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
GERMANY;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
PLASMAPHERESIS;
|
|
EID: 79959848347
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6038.27 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
